NCT04013568

Brief Summary

The investigators are doing this study to determine if there are body composition changes after a 12-week exercise program in breast cancer patients and determine what factors contribute to sustained physical activity after the 12-week exercise program intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Aug 2019

Longer than P75 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2019

Completed
25 days until next milestone

First Posted

Study publicly available on registry

July 9, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

August 28, 2019

Completed
6.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 6, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 6, 2026

Completed
Last Updated

March 31, 2026

Status Verified

March 1, 2026

Enrollment Period

6.5 years

First QC Date

June 14, 2019

Last Update Submit

March 29, 2026

Conditions

Outcome Measures

Primary Outcomes (11)

  • Fat mass

    Measure fat mass (arms, legs, trunk and total) in kg using Dual energy X-ray absorptiometry (DXA) data

    1 day

  • Isometric peak torque

    Measure the peak torque value generated during isometric knee extension/flexion movement evaluation at 60 degrees will be assessed with the HUMAC NORM device

    1 day

  • Lean mass

    Measure lean mass (arms, legs, trunk and total) in kg using Dual energy X-ray absorptiometry (DXA) data

    1 day

  • Bone mass

    Measure bone mass (arms, legs, trunk and total) in kg using Dual energy X-ray absorptiometry (DXA) data

    1 day

  • Waist to Hip ratio (WHR) from manual tape measurement

    Manual physical anthropometry of waist and hip circumferences

    1 day

  • Automatic 3D optical (3DO) scan measurement: girth measurement

    Automated 3DO measurements generate the following: girth in cm measurements across the whole body

    1 day

  • Muscle Function

    Measure the peak torque value generated during isometric knee extension/flexion movement evaluation at 60 degrees will be assessed with the HUMAC NORM device

    1 day

  • Percent fat

    Percent fat (arms, legs, trunk and total) using Dual energy X-ray absorptiometry (DXA) data

    1 day

  • Automatic 3D optical (3DO) scan measurement: length measurement

    Automated 3DO measurements generate the following: length in cm measurements across the whole body

    1 day

  • Automatic 3D optical (3DO) scan measurement: volume measurement

    Automated 3DO measurements generate the following: volume in cm measurements across the whole body

    1 day

  • Bone Mineral Density (spine and total) using Dual energy X-ray absorptiometry (DXA) data

    Bone Mineral Density (spine and total) using Dual energy X-ray absorptiometry (DXA) data

    1 day

Secondary Outcomes (7)

  • Recurrence Free Survival

    5 years

  • BIBCQ-Body Image After Breast Cancer questionnaire

    5 years

  • BFI-Brief Fatigue Innovatory questionnaire

    5 years

  • PHQ-9- Patient Health (Depression) questionnaire

    5 years

  • FACT-G-Functional Assessment of Cancer Therapy-General (Comorbidities)questionnaire

    5 years

  • +2 more secondary outcomes

Study Arms (2)

Group 1 - Agree to Exercise Program

ACTIVE COMPARATOR

12-week exercise program

Other: Exercise

Group 2 - Declines Exercise Program

NO INTERVENTION

Same biometric and biomarker assessment at as Group 1 (at baseline, after 12 weeks and annually) however they will not participate in the exercise sessions

Interventions

First Intervention 12-week exercise program, 3 days/week, 90min exercise sessions at the Rehabilitation Hospital of the Pacific. Private or semi-private (1:1 or 2:1 ratio participant to instructor) sessions, led by Kinesiology students Second Intervention- 12-week exercise program, 2 days/week, 90min exercise sessions at the Rehabilitation Hospital of the Pacific. Group Fitness Classes

Group 1 - Agree to Exercise Program

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • New diagnosis of breast cancer (within the past 2 years, any subtype, stage I-III)
  • Can be undergoing neo/adjuvant treatment (surgery, chemotherapy, radiation or endocrine therapy)
  • Participant is willing and able to comply with the protocol for the duration of the study including undergoing scheduled exercise sessions, completing questionnaires and biometric/biomarker studies
  • Participant must be able to lie flat on their back for up to 10 minutes
  • Participant must be able to stand without aid for at least 2 minutes

You may not qualify if:

  • Participant with breast cancer recurrence
  • Metastatic breast cancer
  • Uncontrolled psychiatric disorder that can affect self-assessment
  • Pregnant patient
  • Participants with any internal artifact (e.g. pacemakers, internal fixation, arthroplasty) or other physical impairment that would alter the body composition assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Hawaii Cancer Center

Honolulu, Hawaii, 96813, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Exercise

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Jami Fukui, MD

    University of Hawaii Cancer Research Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants choose the initial intervention (12-week exercise program (Group1) vs monitoring (Group2)).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2019

First Posted

July 9, 2019

Study Start

August 28, 2019

Primary Completion

March 6, 2026

Study Completion

March 6, 2026

Last Updated

March 31, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations